Ethical Prescribing of Psychotropic Medications for People with Neurodevelopmental Disorders

Ahmed, Z., Fraser, W., Kerr, M. P., Kiernan, C., Emerson, E., Robertson, J., Felce, D., Allen, D., Baxter, H., & Thomas, J. (2000). Reducing antipsychotic medication in people with a learning disability. British Journal of Psychiatry, 176, 42–46.

Article  Google Scholar 

Barratt, M., Jorgensen, M., Deb, S., Limbu, B., Donley, M., Buchholtz, M., Smith, V., & Wilson, N. (2023). Staff perceptions following a training programme about reducing psychotropic medication use in adults with intellectual disability: The need for a realistic professional practice framework. Journal of Applied Research in Intellectual Disabilities, 36, 486–496. https://doi.org/10.1111/jar.13070

Article  PubMed  Google Scholar 

Bertelli, M. O., Azeem, M. W., Underwood, L., Scattoni, M. L., Persico, A. M., Ricciardello, A., Sappok, T., Bergmann, T., Keller, R., Bianco, A., Corti, S., Miselli, G., Lassi, S., Croce, L., Bradley, E., & Munir, K. (2022). Autism spectrum disorder. In M. O. Bertelli, S. Deb, K. Munir, A. Hassiotis, & L. Salvador-Carulla (Eds.), Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder (pp. 369–455). Springer Nature. https://doi.org/10.1007/978-3-319-95720-3_16

Chapter  Google Scholar 

Branford, D. (1996). A review of antipsychotic drugs prescribed for people with learning disabilities who live in Leicestershire. Journal of Intellectual Disability Research, 40(4), 358–368.

Article  PubMed  Google Scholar 

Cervantes, P. E., Matson, J. L., Matheis, M., & Burns, C. O. (2017). Ethical considerations regarding treatment. In J. L. Matson (Ed.), Handbook of Treatments for Autism Spectrum Disorder, Autism and Child Psychopathology Series (pp. 41–58). Springer International Publishing AG. https://doi.org/10.1007/978-3-319-61738-1_3

Chapter  Google Scholar 

Cooper, S.-A., McLean, G., Guthrie, B., McConnachie, A., Mercer, S., Sullivan, S., & Morrison, J. (2015). Multiple physical and mental health comorbidity in adults with intellectual disabilities: Population-based cross-sectional analysis. BMC Family Practice, 16, 110–121. https://doi.org/10.1186/s12875-​015-​0329-3

Article  PubMed  PubMed Central  Google Scholar 

Coury, D. L., Anagnostou, E., Manning-Courtney, P., Reynolds, A., Cole, L., McCoy, R., Whitaker, A., & Perrin, J. M. (2012). Use of psychotropic medication in children and adolescents with autism spectrum disorders. Pediatrics, 130(suppl 2), s69–s76. https://doi.org/10.1542/peds.2012-0900D

Article  PubMed  Google Scholar 

de Kuijper, G. M., & Hoekstra, P. J. (2018). An open-label discontinuation trial of long-term, off-label antipsychotic medication in people with intellectual disability: Determinants of success and failure. The Journal of Clinical Pharmacology, 58(11), 1418–1426.

Article  PubMed  Google Scholar 

de Kuijper, G., Hoekstra, P., Visser, F., Scholte, F. A., Penning, C., & Evenhuis, H. (2010). Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: Prevalence and reasons for prescription. Journal of Intellectual Disability Research, 54(7), 659–667. https://doi.org/10.1111/j.1365-2788.2010.01275.x

Article  PubMed  Google Scholar 

de Kuijper, G., Mulder, H., Evenhuis, H., Scholte, F., Visser, F., & Hoekstra, P. J. (2013). Determinants of physical health parameters in individuals with intellectual disability who use long-term antipsychotics. Research in Developmental Disabilities, 34, 2799–2809. https://doi.org/10.1016/j.ridd.2013.05.016

Article  PubMed  Google Scholar 

de Kuijper, G., Evenhuis, H., Minderaa, R. B., & Hoekstra, P. J. (2014). Effects of controlled discontinuation of long-term used antipsychotics for behavioural symptoms in individuals with intellectual disability. Journal of Intellectual Disability Research, 58(1), 71–83.

Article  PubMed  Google Scholar 

de Kuijper, G., de Haan, J., Deb, S., & Shankar, R. (2022). Withdrawing antipsychotics for challenging behaviours in adults with intellectual disabilities: Experiences and views of the experts by experience. International Journal of Environmental Research and Public Health, 19, 15637. https://doi.org/10.3390/ijerph192315637

Article  PubMed  PubMed Central  Google Scholar 

Deb, S., & Limbu, B. (2022). Support staff liaising effectively with family caregivers: Findings from a co-design event and recommendation for a staff training resource. Frontiers in Psychiatry, 13, 977442. https://doi.org/10.3389/fpsyt.2022.977442

Article  PubMed  PubMed Central  Google Scholar 

Deb, S., Clarke, D., & Unwin, G. (Eds.). (2006). Using medication to manage behaviour problems among adults with a learning disability: Quick reference guide (QRG). University of Birmingham ENCAP The Royal College of Psychiatrists www.ld-medication.bham.ac.uk

Google Scholar 

Deb, S., Kwok, H., Bertelli, M., Salvador-Carulla, L., Bradley, E., Torr, J., & Barnhill, J. (2009). International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities. World Psychiatry, 8(3), 181–186. https://doi.org/10.1002/j.2051-5545.2009.tb00248.x

Article  PubMed  PubMed Central  Google Scholar 

Deb, S., Unwin, G., & Deb, T. (2015). Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour. Journal of Intellectual Disability Research, 59(1), 11–25. https://doi.org/10.1111/jir.12119

Article  PubMed  Google Scholar 

Deb, S., Limbu, B., Unwin, G., Woodcock, L., Cooper, V., & Fullerton, M. (2021). Short-term psycho-education for caregivers to reduce overmedication of people with intellectual disabilities (SPECTROM): Development and field testing. International Journal of Environmental Research and Public Health, 18, 13161. https://doi.org/10.3390/ijerph182413161

Article  PubMed  Google Scholar 

Deb, S., Perera, B., Krysta, K., Ozer, M., Bertelli, M., Novell, R., Wieland, J., & Sappok, T. (2022a). The European guideline on the assessment and diagnosis of psychiatric disorders in adults with intellectual disabilities. European Journal of Psychiatry, 36, 11–25. https://doi.org/10.1016/j.ejpsy.2021.10.002

Article  Google Scholar 

Deb, S., Bertelli, M. O., & Rossi, M. (2022b). Psychopharmacology. In M. O. Bertelli, S. Deb, K. Munir, A. Hassiotis, & L. Salvador-Carulla (Eds.), Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder (pp. 247–279). Springer Nature, (chapter 11). https://doi.org/10.1007/978-3-319-95720-3_11

Chapter  Google Scholar 

Deb, S., Unwin, G. L., Cooper, S.-A., & Rojahn, J. (2022c). Problem behaviours. In M. O. Bertelli, S. Deb, K. Munir, A. Hassiotis, & L. Salvador-Carulla (Eds.), Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder (pp. 145–186). Springer Nature, (chapter 7). https://doi.org/10.1007/978-3-319-95720-3_7

Chapter  Google Scholar 

Deb, S., Roy, M., & Limbu, B. (2023a). Psychopharmacological treatments for psychopathology in people with intellectual disabilities and/or autism spectrum disorder. British Journal of Psychiatry Advances, 29, 322–333. https://doi.org/10.1192/bja.2022.61

Article  Google Scholar 

Deb, S., Roy, M., Limbu, B., Akrout Brizard, B., Murugan, M., Roy, A., & Santambrogio, J. (2023b). Randomised controlled trials of antipsychotics for people with autism spectrum disorder: A systematic review and a meta-analysis. Psychological Medicine (Early View). https://doi.org/10.1017/S003329172300212X

Department of Constitutional Affairs. (2005). Mental Capacity Act 2005. The Stationery Office.

Google Scholar 

Elford, H., Beail, N., & Clarke, Z. (2010). A very fine line’: Parents’ experiences of using restraint with their adult son/daughter with intellectual disabilities. Journal of Applied Research in Intellectual Disabilities, 23, 75–84. https://doi.org/10.1111/j.1468-3148.2009.00548.x

Article  Google Scholar 

Glover, G., Williams, R., Branford, D., Avery, R., Chauhan, U., Hoghton, M., & Bernard, S. (2015). Prescribing of psychotropic drugs to people with learning disabilities and/or autism by general practitioners in England. Public Health England.

Google Scholar 

Gore, N. J., Sapiets, S. J., Denne, L. D., Hastings, R. P., Toogood, S., MacDonald, A., Baker, P., Allen, D., Apanasionok, M. M., Austin, D., Bowring, D. L., Bradshaw, J., Corbett, A., Cooper, V., Deveau, R., Hughes, J. C., Jones, E., Lynch, M., McGill, P., et al. (2022). Positive behavioural support in the UK: A state of the nation report. International Journal of Positive Behavioural Support, 12(1), 4–39.

Google Scholar 

Gupta, S., Cahill, J. D., & Miller, R. (2018). Deprescribing antipsychotics: A guide for clinicians. British Journal of Psychiatry Advances, 24, 295–302. https://doi.org/10.1192/bja.2018.2

Article  Google Scholar 

Hall, S., & Deb, S. (2008). A qualitative study on the knowledge and views that people with learning disabilities and their carers have of psychotropic medication prescribed for behaviour problems. Advances in Mental Health and Learning Disability, 2(1), 29–37.

Article  Google Scholar 

Hassiotis, A., Kimona, K., Moncrieff, J., & Deb, S. (2016). A stakeholder consultation about future research of psychotropic medication use and behaviour support for adults with intellectual disabilities who present with behaviours that challenge: Feasibility of future research. NOCLOR https://www.ucl.ac.uk/psychiatry/sites/psychiatry/files/stakeholder-consultation-document.pdf

Google Scholar 

Jobski, K., Höfer, J., Hoffmann, F., & Bachmann, C. (2017). Use of psychotropic drugs in patients with autism spectrum disorders: A systematic review. Acta Psychiatrica Scandinavica, 135(1), 8–28. https://doi.org/10.1111/acps.12644

Article  PubMed  Google Scholar 

Knox, M. (2000). Family control: The views of families who have a child with an intellectual disability. Journal of Applied Research in Intellectual Disabilities., 13, 17–28. https://doi.org/10.1046/j.1468-3148.2000.00001.x

Article  Google Scholar 

Luiselli, J. K. (2021). Applied behavior analysis treatment of violence and aggression in persons with neurodevelopmental disabilities. Springer.

Book  Google Scholar 

Mandell, D. S., Morales, K. H., Marcus, S. C., Stahmer, A. C., Doshi, J., & Polsky, D. E. (2008). Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics, 121, e441–e448.

Article  PubMed  Google Scholar 

Murray, M. L., Hsia, Y., Glaser, K., Simonoff, E., Murphy, D. G., Asherson, P. J., Eklund, H., & Wong, I. C. (2014). Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care. Psychopharmacology, 231, 1011–1021.

Article  PubMed  Google Scholar 

National Disabilities Insurance Scheme (NDIS) Quality and Safeguards Commission. (2020). Regulated restrictive practices guide. NDIS Quality and Safeguards Commission https://www.ndiscommission.gov.au/sites/default/files/2022-02/regulated-restrictive-practice-guide-rrp-20200.pdf (retrieved 15th September 2023)

Google Scholar 

National Institute for Health and Care Excellence (NICE). (2015). Challenging behaviour and learning disabilities: Prevention and interventions for people with learning disabilities whose behaviour challenges. In NICE Guideline 11 Methods evidence and recommendations.

Google Scholar 

Oliver-Africano, P. C., Dickens, S., Ahmed, Z., Bouras, N., Cooray, S., Deb, S., Knapp, M., Hare, M., Meade, M., Reece, B., Bhaumik, S., Harley, D., Paichaud, J., Regan, A., Thomas, D. A., Keratela, S., Rao, B., Dzendrowskyj, T., Lenôtre, L., et al. (2010). Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities. Journal of Intellectual Disability Research, 54, 17–25. https://doi.org/10.1111/j.1365-2788.2009.01195.x

Article  PubMed  Google Scholar 

Olson, D. A., Ingram, W., & Mann, J. R. (2002). Combination of olanzapine and divalproex for agitation in individuals with profound mental retardation. Journal of Clinical Psychopharmacology, 22(5), 529–530.

Article  PubMed  Google Scholar 

Planès, S., Villier, C., & Mallaret, M. (2016). The nocebo effect of drugs. Pharmacology Research & Perspective, 4, e00208.

Article  Google Scholar 

Ramerman, L., Hoekstra, P. J., & de Kuijper, G. (2018). Health-related quality of life in people with intellectual disability who use long-term antipsychotic drugs for challenging behaviour. Research in Developmental Disabilities, 75, 49–58.

Article  PubMed  Google Scholar 

Ratti, V., Hassiotis, A., Crabtree, J., Deb, S., Gallagher, P., & Unwin, G. (2016). The effectiveness of person-centred p

留言 (0)

沒有登入
gif